| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $3.64 | $3.22 | $3.44 | $2.85 |
| Inventory | ||||
| Total current assets | $80.54 | $46.59 | $107.62 | $71.15 |
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1254.46 | $1258.79 | $1324.38 | $1323.67 |
| Current liabilities | ||||
| Accounts payable | $37.45 | $34.72 | $34.25 | $34.35 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $349.01 | $335.44 | $329.7 | $172.26 |
| Long term debt | $471.54 | $483.35 | $542.48 | $694.38 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $820.55 | $818.79 | $872.18 | $870.87 |
| Shareholders' equity | ||||
| Retained earnings | -$114.88 | -$111.5 | -$103.95 | -$109.09 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $2.85 | $7.32 | $3.69 | $2.5 |
| Inventory | ||||
| Total current assets | $71.15 | $106.29 | $12.04 | $28.6 |
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1323.67 | $1450.32 | $1421.18 | $1404.9 |
| Current liabilities | ||||
| Accounts payable | $34.35 | $36.97 | $21.21 | $23.1 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $172.26 | $230.16 | $177.21 | $75.6 |
| Long term debt | $694.38 | $683.39 | $681.17 | $776 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $870.87 | $928.18 | $881.11 | $879.7 |
| Shareholders' equity | ||||
| Retained earnings | -$109.09 | -$41.14 | -$4.05 | -$3 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $30.44 | $32.33 | $32.46 | $32.87 |
| Cost of revenue | ||||
| Gross Profit | $16.26 | $17.52 | $16.59 | $17.35 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $4.13 | $1.84 | $1.7 | $0.85 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$15.51 | -$21.26 | -$9.74 | -$22.43 |
| Net income | ||||
| Net income | -$3.38 | -$7.55 | $5.14 | -$5.94 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $132.2 | $143.6 | $138.5 | $139.4 |
| Cost of revenue | ||||
| Gross Profit | $72.55 | $86.5 | $82.6 | $83.7 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | -$2.29 | $3.6 | $12.7 | $4.4 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$114.08 | -$66.3 | -$18.3 | -$39.4 |
| Net income | ||||
| Net income | -$40.62 | $16.5 | $51 | $39.8 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $39.26 | $44.34 | -$3.92 | $32.45 |
| Financing activities | ||||
| Dividends paid | -$31.15 | |||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$92.02 | -$78.22 | -$11.7 | -$106.94 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.73 | $0.63 | -$0.75 | -$0.55 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $32.45 | -$72.8 | -$31.7 | -$19.4 |
| Financing activities | ||||
| Dividends paid | -$31.15 | -$48.6 | -$47.2 | -$42.2 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$106.94 | -$26.4 | -$64.7 | -$53.1 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$0.55 | $4.1 | -$19.1 | $18.9 |
| Market cap | $127.30M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 14.30M |
| Revenue | $128.09M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$11.73M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -10.85 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.99 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.82 |
|---|---|
| ROA | -0.91% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.23 |
| Quick ratio | N/A |